NCT06485843: An ongoing trial by Ageless Biotech, Inc.
This trial is ongoing. It must report results 3 years, 3 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06485843 |
|---|---|
| Title | An Open Label Phase IIb Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | May 21, 2025 |
| Completion date | March 31, 2028 |
| Required reporting date | March 31, 2029, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |